Capecitabine is a cancer medication that interferes with the growth of cancer cells and slows their spread in the body.

Capecitabine is used to treat breast cancer and colon or rectum cancer that has spread to other parts of the body.

Capecitabine is often used in combination with other cancer medications and/or radiation treatments.

Capecitabine belongs to Anti-Cancer Therapeutic Category.

Aarti Healthcare Division of Aarti Industries Limited manufactures Capecitabine with an annual capacity of 36000 Kgs.

Capecitabine is available in the following Specifications/Grades.

Specification USP
EDMF (CTD) Available
USDMF 22954


Aarti Healthcare Division also offers following Intermediates for Capecitabine.

Sr. No. Intermediate CAS Number
1 1,2,3-Tri-O-acetyl-5-deoxy-D-ribofura nose 62211-93-2


Bicalutamide Ifosfamide Cyclophosphamide
Mesna Mercaptopurine Azathioprine


Note :

  1. Intermediates of above APIs will be available.
  2. Products Under Patent will not be sold until patent expiration in buyer's country.
  3. Purchase of any Patented Product will be sole responsibility of the Buyer.